Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-28

Clinical Trial Update: Enhanced Motor Recovery Using Serotonergic Agents in Stroke [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating serotonergic agents to enhance motor recovery in patients with chronic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Serotonergic agents (unspecified)

Snippet

Sponsor: Shirley Ryan AbilityLab | Conditions: Patients With Chronic Stroke | Phase 1 | Status: COMPLETED